Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro.
第一作者:
Zhe,Liu
第一单位:
Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.
作者:
主题词
抗肿瘤药(Antineoplastic Agents);适体, 核苷(Aptamers, Nucleotide);碱基序列(Base Sequence);乳腺肿瘤(Breast Neoplasms);DNA引物(DNA Primers);多柔比星(Doxorubicin);女(雌)性(Female);流式细胞术(Flow Cytometry);基因, erbB-2(Genes, erbB-2);人类(Humans);SELEX适体技术(SELEX Aptamer Technique);肿瘤细胞, 培养的(Tumor Cells, Cultured)
DOI
10.1186/1479-5876-10-148
PMID
22817844
发布时间
2021-10-21
- 浏览4
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文